Physician profile
Maria C Carrillo
NPI 1588673289
$1,469.86
in general payments reported to CMS, 2019-2025
13 companies · $70.11 in 2025
The $70.11 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $209 · 2021: $180 · 2023: $120 · 2024: $194 · 2025: $70.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $607.65 | 2019-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $122.45 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.54 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $119.00 | 2019 | |
| Vapotherm INC | $97.00 | 2023 | Vapotherm |
| Abbott Laboratories | $92.47 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $84.22 | 2020 | |
| Cook Medical LLC | $34.16 | 2021 | |
| Merck Sharp & Dohme LLC | $23.96 | 2025 | Zerbaxa |
| Boston Scientific Corporation | $22.82 | 2023 | Exalt Model D |
| Alexion Pharmaceuticals, INC. | $19.59 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Carrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.